Fernández Montes, AnaMartinez-Lago, Nievesde la Cámara Gomez, JuanBrozos Vázquez, Elena MaríaCandamio Folgar, SoniaCarmona Campos, MartaCousillas Castiñeiras, AntíaCovela Rúa, MartaGallardo Martín, ElenaGonzález Villarroel, PaulaGraña Suarez, BegoñaJorge Fernández, MónicaPellón Augusto, María LuzQuintero Aldana, GuillermoRomero Reinoso, CarlosSalgado Fernández, MercedesVázquez Rivera, FranciscaAyuso-Alvarez, Ana MariaCulqui, Dante RogerMéndez Méndez, José CarlosRIGhT-sens Working Group2022-04-082022-04-082021-06-03Healthcare (Basel). 2021 Jun 3;9(6):665.2227-9032http://hdl.handle.net/20.500.12105/13977Background: In recent years, abundant scientific evidence has been generated based on clinical trials (CT) in the field of oncology. The general objective of this paper is to find out the extent to which decision making is based on knowledge of the most recent CT. Its specific objectives are to pinpoint difficulties with decision making based on the CT performed and find out the motivations patients and clinicians have when taking part in a CT. Methodology: Combined, prospective study, based on the Delphi method. A lack of correspondence between the people who take part in CT and patients who come for consultation has been identified. A need for training in analysing and interpreting CT has also been identified and a lack of trust in the results of CT financed by the pharmaceutical industry itself has been perceived. Conclusions: There is a difficulty in selecting oncological treatment due to the lack of correspondence between the patients included in the CT and patients seen in consultation. In this process, real world data studies may be highly useful, as they may provide this group with greater training in interpreting CT and their results.engVoRhttp://creativecommons.org/licenses/by/4.0/Delphi methodViews digestive oncology specialistsAtribución 4.0 Internacional342050269666510.3390/healthcare9060665Healthcare (Basel, Switzerland)open access